More than two years after buying Merck's OTC unit and local player Dihon, bringing together three separate consumer care businesses in China remains a…

Vietnam has been one of the fastest-growing economies in Asia in recent years, and Sanofi has just cut a deal to give it a stronger position in the market.

With Mitsubishi Tanabe deal, Sun Pharma takes a basket of new meds into Japan, a market where Indian drugmakers are under-represented.

"Binding" $1 billion offers are said to be on the table as Indian drugmakers Aurobindo and Intas go head-to-head for Teva's generics business in…

By selling its Wako chemicals unit, the top Japanese drugmaker Takeda could raise $1 billion for reinvestment in its pipeline.

Rumors of Merck brand sale in India raise questions about the future of its generic drug division.

Sanofi provided insight into the logistics hurdles faced by vaccine makers in China after a distribution and sales rule changed.

China's Shanghai Fosun Pharmaceuticals has reportedly won a bidding war for India's privately held injectable maker Gland Pharma in a rare cross-…

Exceptions on 15 ingredients from a banned plant run by China's Zhejiang Hisun Pharmaceuticals have raised questions on the ability of inspectors to…

M&A